Authors


Quinn Everts

Latest:

Don’t Get Caught Up With a HIPAA Violation

Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?


Natalie Catalan, PharmD candidate

Latest:

Review of FDA Approvals for Pediatric Obesity Management

GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.


Chelsee Jensen, PharmD, BCPS

Latest:

Q&A: Challenges Health Systems May Face When Integrating Biosimilars

A conversation with Chelsee Jensen, PharmD, BCPS, director of formulary management at the Mayo Clinic.



Maxim Mikheev, PhD, MD, MSc

Latest:

How Rare Cannabinoids Are Disrupting the Pharmaceutical Industry

By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.


Frank Diamond

Latest:

FDA Issues EUA for First Oral Antiviral Pill for COVID-19

The pill, Paxlovid, showed an 88% decrease in hospitalization and death for those taking it 5 days after experiencing COVID-19 symptoms.


Erin O'Brien

Latest:

NDA for Investigational Schizophrenia Treatment Submitted to FDA

The NDA was submitted for investigational muscarinic antipsychotic, KarXT (xanomeline-trospium), which functions as a dual M1/M4 muscarinic acetylcholine receptor agonist within the central nervous system.


David Blair

Latest:

How LucyRx is Changing the Traditional PBM Model

LucyRx is empowering pharmacists and impacting patients’ health outcomes with its business model unlike other market-leading pharmacy benefit managers.


Michael Kleinrock

Latest:

How US Patients Are Using, Spending on Prescription Drugs

With the company’s dedication to providing crucial data for pharmacy stakeholders, IQVIA’s Lead Research Director Michael Kleinrock discussed the current trends in patients’ medication use.


Stanley V. Campbell, Jr

Latest:

Q&A: What AI Is, How It’s Helping Pharmacies with Compliance | NCPDP 2025

Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss the basics of AI and how it’s assisting with compliance.


Amanda Clouser, PharmD

Latest:

Review: Harmful Excipients for Pediatric Patients

Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.


Megan Wright, CPhT-Adv

Latest:

Pharmacy Technicians Provide Patient Assistance With Oral Oncolytics

Pharmacy technicians can provide a great amount of value for patients navigating the financial toxicity of cancer treatment.


Cami Agena, Esq

Latest:

Where PBM Reform is Headed in 2025, Beyond | NCPDP 2025

Attorneys from The Phoenix Law Group joined Drug Topics at NCPDP 2025 to discuss the current state of pharmacy benefit manager reform and where it may end up in the near future.


Julia Bonavitacola

Latest:

Blood-Based Test Demonstrates High Sensitivity for Colorectal Cancer

A blood-based cell-free DNA (cfDNA) test was able to find patients at increased risk of colorectal cancer (CRC), advanced neoplasia, and advanced precancerous lesions.


Sarah Schang, PharmD

Latest:

Pharmacists Help Patients Manage Chronic Pain

Chronic pain is associated with a significant financial burden, with an estimated cost placed at $650 billion annually in the US.


Catherine Y. Spong, MD

Latest:

Protecting Our Most Vulnerable Through Vaccination

For more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.


Cherokee Layson-Wolf, PharmD, BCACP, FAPhA

Latest:

Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, discusses the impact of shifting guidance on vaccination strategies.



Olivia G. Funk, PharmD Candidate

Latest:

Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common Cold

Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.


Shams Alrubaie, PharmD Candidate

Latest:

New Advances in Breast Cancer Therapy

Breast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.


David Hutton

Latest:

Two Eye Diseases Could Contribute to Common Blinding Eye Condition

The study could lead to early diagnosis and treatment of age-related macular degeneration.


Lauren Jonas, MD

Latest:

Preventing Severe Respiratory Infections in Children

A refresher on best interventions for common respiratory disorders in children.


Mike Hennessy Jr, Chairman & CEO, MJH Life Sciences

Latest:

As Health Care Continues to Evolve, Pharmacy Education Remains Essential

Pharmacists can now showcase their skills within the health care industry by counseling patients and continuing to learn and grow with them.


Ollin Sykes, CPA, CITP

Latest:

Focus on DIR Fees: 3 Ways to Manage Them

When investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.


Bonnie Bond, CPA

Latest:

Maximizing Adherence Packaging for Patient Health and Pharmacy Growth

Is adherence packaging technology a big investment for a community or independent pharmacy?


Carrie W. Nemerovski, PharmD

Latest:

OTC Drug Interaction Considerations in the Cough and Cold Aisle

OTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.


Nathan Ramsbacher, PharmD

Latest:

Q&A: Expert Discusses the Critical Role of Clinical Pharmacists in Diabetes Management

Clinical pharmacists transform diabetes care by leveraging manufacturer-sponsored patient assistance programs to dramatically improve medication access.


Simran M. Doshi, BSPH, PharmD Candidate

Latest:

Pharmacist’s Role Expands in the Era of Cannabis Rescheduling

Rescheduling cannabis empowers pharmacists to lead in patient care by evaluating safety, interactions, and formulations while providing education.


Kris Rhea

Latest:

Focus on What Matters: Sustaining Your Pharmacy in 2025

What are some key strategies for keeping your pharmacy thriving in 2025?


Janessa Maldonado, PharmD candidate

Latest:

Navigating Pediatric ADHD Medication Shortages

Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.

© 2025 MJH Life Sciences

All rights reserved.